Feedback / Questions
IkT-148009 - Inhibikase, Clintrex
https://www.prnewswire.com/news-releases/inhibikase-therapeutics-announces-dosing-of-first-patient-in-its-phase-2-201-clinical-trial-of-ikt-148009-to-treat-parkinsons-disease-301825634.html
May 16, 2023
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next